TCF7 and neoplasm: Using a human immunocompetent patient-derived tumor organoid (PDTO) platform, we demonstrated that treatment with AG1 during T cell rapid expansion from autologous PBMCs resulted in elevated TCF1 expression, mimicking our mouse data.